These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 3316850)

  • 1. Graft versus host disease following transfusion of normal blood products to patients with malignancies.
    Kessinger A; Armitage JO; Klassen LW; Landmark JD; Hayes JM; Larsen AE; Purtilo DT
    J Surg Oncol; 1987 Nov; 36(3):206-9. PubMed ID: 3316850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transfusion-induced graft-versus-host disease in patients with malignant lymphoma. A case report and review of the literature.
    Spitzer TR; Cahill R; Cottler-Fox M; Treat J; Sacher R; Deeg HJ
    Cancer; 1990 Dec; 66(11):2346-9. PubMed ID: 2245390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute graft-versus-host disease resulting from normal donor blood transfusions.
    Burns LJ; Westberg MW; Burns CP; Klassen LW; Goeken NE; Ray TL; Macfarlane DE
    Acta Haematol; 1984; 71(4):270-6. PubMed ID: 6426240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatal graft-versus-host disease following blood transfusion in Hodgkin's disease documented by HLA typing.
    Dinsmore RE; Straus DJ; Pollack MS; Woodruff JM; Garrett TJ; Young CW; Clarkson BD; Dupont B
    Blood; 1980 May; 55(5):831-4. PubMed ID: 7362871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Post-transfusion graft versus host disease in a patient with Hodgkin's disease].
    Tomás Martínez JF; Abad Hernández MJ; Cortina de la Calle MP; Canut Blasco A; Nieto González MJ; Corral Alonso M; San Miguel Izquierdo JF; López-Borrasca A
    Med Clin (Barc); 1989 Apr; 92(13):503-6. PubMed ID: 2747313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Graft-versus-host disease in rhabdomyosarcoma following transfusion with nonirradiated blood products.
    Labotka RJ; Radvany R
    Med Pediatr Oncol; 1985; 13(2):101-4. PubMed ID: 3856732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of transfusion-associated graft-versus-host disease not prevented by white cell-reduction filters.
    Akahoshi M; Takanashi M; Masuda M; Yamashita H; Hidano A; Hasegawa K; Kasajima T; Shimizu M; Motoji T; Oshimi K
    Transfusion; 1992 Feb; 32(2):169-72. PubMed ID: 1542924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfusion-associated graft-versus-host disease in patients with Hodgkin's disease and T cell lymphoma.
    Baglin TP; Joysey VC; Horsford J; Johnson RT; Broadbent V; Marcus RE
    Transfus Med; 1992 Sep; 2(3):195-9. PubMed ID: 1308830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatal graft v host disease in a child with neuroblastoma following a blood transfusion.
    Kennedy JS; Ricketts RR
    J Pediatr Surg; 1986 Dec; 21(12):1108-9. PubMed ID: 3794974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of graft-versus-host disease following red cell concentrate (MAP-CRC) transfusion].
    Nakamoto T; Nishi S; Shindoh M; Hayashi M; Yukioka H; Fujimori M; Maekawa N
    Masui; 1995 Sep; 44(9):1261-4. PubMed ID: 8523663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatal graft-versus-host disease associated with transfusions of HLA-matched, HLA-homozygous platelets from unrelated donors.
    Benson K; Marks AR; Marshall MJ; Goldstein JD
    Transfusion; 1994 May; 34(5):432-7. PubMed ID: 8191569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of graft-versus-host disease in high risk patients by depletion of CD4+ and reduction of CD8+ lymphocytes in the marrow graft.
    Herrera C; Torres A; García-Castellano JM; Roman J; Martin C; Serrano J; Falcon M; Alvarez MA; Gomez P; Martinez F
    Bone Marrow Transplant; 1999 Mar; 23(5):443-50. PubMed ID: 10100557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic transplantation combining mobilized blood and bone marrow in patients with refractory hematologic malignancies.
    Nemunaitis J; Rosenfeld C; Collins R; Pallansch P; Piñeiro L; Ohr S; Waxman D; Stone M; Fay J; Miller W
    Transfusion; 1995 Aug; 35(8):666-73. PubMed ID: 7631407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Graft versus host disease with fatal outcome after administration of filtered erythrocyte concentrates].
    Heim MU; Munker R; Sauer H; Wolf-Hornung B; Knabe H; Holler E; Böck M; Mempel W
    Beitr Infusionsther; 1992; 30():178-81. PubMed ID: 1284701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfusion-associated graft-versus-host disease: report of an occurrence following the administration of irradiated blood.
    Lowenthal RM; Challis DR; Griffiths AE; Chappell RA; Goulder PJ
    Transfusion; 1993 Jun; 33(6):524-9. PubMed ID: 8516797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfusion-associated graft vs. host disease in a patient with high-grade B-cell lymphoma. Should cellular products for patients with non-Hodgkin's lymphoma be irradiated?
    Gelly KJ; Kerr R; Rawlinson S; Norris A; Bowen DT
    Br J Haematol; 2000 Jul; 110(1):228-9. PubMed ID: 10931004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Transfusion-associated graft-vs-host disease in a patient with Hodgkin's disease].
    Lillevang ST; Andersen CB; Schmidt KG; Riisom K
    Ugeskr Laeger; 1992 Oct; 154(43):2979-80. PubMed ID: 1462387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autografting followed by nonmyeloablative immunosuppressive chemotherapy and allogeneic peripheral-blood hematopoietic stem-cell transplantation as treatment of resistant Hodgkin's disease and non-Hodgkin's lymphoma.
    Carella AM; Cavaliere M; Lerma E; Ferrara R; Tedeschi L; Romanelli A; Vinci M; Pinotti G; Lambelet P; Loni C; Verdiani S; De Stefano F; Valbonesi M; Corsetti MT
    J Clin Oncol; 2000 Dec; 18(23):3918-24. PubMed ID: 11099321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic bone marrow transplantation for relapsed and refractory Hodgkin's disease and non-Hodgkin's lymphoma.
    Dann EJ; Daugherty CK; Larson RA
    Bone Marrow Transplant; 1997 Sep; 20(5):369-74. PubMed ID: 9339751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brentuximab vedotin prior to allogeneic stem cell transplantation increases survival in chemorefractory Hodgkin's lymphoma patients.
    Gaudio F; Mazza P; Mele A; Palazzo G; Carella AM; Delia M; Pisapia G; Pastore D; Cascavilla N; Pavone V; Specchia G
    Ann Hematol; 2019 Jun; 98(6):1449-1455. PubMed ID: 30868307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.